环码 - Biotechnology, Health Care Company Profile, Funding Rounds and Investors

General Information

Company Name

环码

Founded Year

2021

Location (Offices)

China +1

Founders / Decision Makers

Number of Employees

Industries

Biotechnology, Health Care, Life Sciences

Funding Stage

Series A

Social Media

环码 - Company Profile

CirCode is an innovative biotechnology company based in China, founded in 2021. The company focuses on the development of Circular RNA therapeutics, with a commitment to realizing the full potential of mRNA science for patients. Compared to linear RNA, circular RNA is more stable and less immunogenic, providing superiority in a broader therapeutic area. CirCode has developed proprietary platform technologies and holds multiple patent families covering this new technology with pending applications worldwide. The company's last investment was a Series A investment on 15 August 2023. The investors in this round included Johnson & Johnson Innovation – JJDC and Chaoxian Fund. CirCode aims to promote the transformation of scientific and technological achievements for the benefit of mankind. For more information, please visit www.circodebio.com.

Taxonomy: Innovative, Circular RNA, Therapeutics, Drug Development, Platform Technologies, Patent, Scientific Advancement, Technological Achievements, Nucleic Acid Drugs, Pharmaceutical, Medical Research, RNA, Biomedical